Find a Startup

Impacting society, creating change

Technologies developed at Ohio State are changing the world. Learn more about the startups that are a part of the Ohio State portfolio as of June 30, 2021, below. 

Search for a Startup below

Categories Filter
  • All
  • Advanced Materials
  • Agriculture, Food Science & Nutrition
  • Animal Health
  • Electronics, Communications & Networking
  • Energy & Environment
  • Health & Wellness
  • Healthcare IT
  • Medical Devices, Diagnostics & Imaging
  • Research Tools & Reagents
  • Robotics, Sensors & Advanced Manufacturing
  • Software & Information Technology
  • Therapeutics, Drug Delivery & Biotechnology
Showing 1-5 of 105 results
Vitranu Inc.
Therapeutics, Drug Delivery & Biotechnology

Vitranu, Inc. is developing a Tunable Extended Release Capsule (TERCTM) for biologic pharmaceuticals delivered via intravitreal injection. The company uses novel electrospinning technology to produce a tiny, double-walled, tunable capsule that can be filled with either biologic or small molecule therapeutics.

College of Engineering
License Fiscal Year: 2021
Inventor(s): Pengfei Jiang; Katelyn Swindle-Reilly; and Matthew Orr
CEO: Gordon Bethwaite
Nanofiber Solutions, Inc.
Therapeutics, Drug Delivery & Biotechnology

Nanofiber Solutions is a regenerative medicine company developing a new class of implants for the $20B soft tissue/organ repair/regeneration market. Its electrospun nanofiber substrate technology is used to build off-the-shelf scaffolds critical in the development of life-saving and life-changing, tissue engineered implants. Nanofiber’s products are used as a means to increase stem cell expansion rates for cellular therapy companies working on personalized treatments.

College of Engineering
License Fiscal Year: 2010
Inventor(s): John Lannutti
CEO: Ross Kayuha
Clarametyx Biosciences
Therapeutics, Drug Delivery & Biotechnology

Clarametyx Biosciences is combating the formidable challenge of persistent antibiotic-resistant infections through an innovative technology platform that targets the biofilm—a protective layer around bacteria—to enable a more effective immune response or antibiotic intervention. The Columbus, Ohio-based company is building a dynamic pipeline of immune-enabling therapies and vaccines for chronic and recurrent bacterial infections associated with biofilms. Its lead candidate, CMTX-001, is a humanized monoclonal antibody in preclinical development for hospital-acquired pneumonia.

College of Medicine
License Fiscal Year: 2020
Inventor(s): Amer Amal
CEO: Michael Triplett
Basking Biosciences Inc.
Therapeutics, Drug Delivery & Biotechnology

Ischemic stroke, a condition where a clot blocks blood flow to the brain, affects approximately 700,000 people annually in the U.S. Ischemic strokes result in 140,000 deaths each year and are a leading cause of long-term disability. Rapid restoration of blood flow to the brain is the only medical intervention proven to improve outcomes but only approximately 15-20% of patients qualify for either of the two FDA approved treatments.

College of Medicine
License Fiscal Year: 2021
Inventor(s): Shahid Nimjee
CEO: Richard Shea
STEMcoding Education Ohio
Software & Information Technology

STEMCoding was formed to help students and teachers understand how computer science and data science relate to the traditional STEM subjects of science, technology, engineering and math through the development of training materials, camps, videos and web resources.

College of Arts and Sciences
License Fiscal Year: 2021
Inventor(s): Christopher Orban
CEO: Christopher Orban